ACM
MDT icon

Archon Capital Management’s Medtronic MDT Stock Holding History

Archon Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-32,250
Closed -$2.6M – 26
2017
Q1 		$2.6M Buy
32,250
+1,330
+4% +$104K 3.7% 11
2016
Q4 		$2.2M Buy
+30,920
New +$2.43M 3.79% 12

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Archon Capital Management's MDT Position: Q2 2017 in Review

Archon Capital Management sold out of Medtronic (MDT) in Q2 2017, closing a stake of 32,250 shares — an estimated $2.6M sold.

Archon Capital Management first reported a position in MDT in Q4 2016 and held it in 2 quarters. The position peaked at $2.6M in Q1 2017. 1,280 funds tracked by Wall St. Rank hold MDT as of Q2 2017.

  • Archon Capital Management reported no remaining Medtronic position as of Q2 2017 after selling out during the quarter.
  • Archon Capital Management sold 32,250 Medtronic shares in Q2 2017, an estimated $2.6M.
  • Archon Capital Management first reported a position in Medtronic in Q4 2016 and held it in 2 quarters.
  • Archon Capital Management's Medtronic position peaked at $2.6M in Q1 2017.
  • 1,280 funds tracked by Wall St. Rank held Medtronic as of Q2 2017.

Based on Archon Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.